AKT2 and breast cancer: And for the first time, we found that ERα-positive BC tissues showed higher AKT2 expression levels than ERα-negative BC tissues (P < 0.05, Figure 5F), suggesting that AKT2 may be a potential biomarker for BC detection and has significance to differentiate ERα-positive BC in clinical tissue samples.